{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:22:58Z","timestamp":1784874178219,"version":"3.55.0"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,3,25]]},"DOI":"10.18632\/aging.102919","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T21:24:18Z","timestamp":1585171458000},"page":"4918-4930","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer"],"prefix":"10.18632","volume":"12","author":[{"given":"Linli","family":"Hu","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Zhengzhou University, Reproductive Medicine, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sir Run Run Shaw Hospital of Zhejiang University, Reproductive Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Quan","sequence":"additional","affiliation":[{"name":"Southern Medical University, Reproductive Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiang","family":"Lv","sequence":"additional","affiliation":[{"name":"Second Affiliated Hospital of Wenzhou Medical University, Reproductive Medicine, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Qian","sequence":"additional","affiliation":[{"name":"Peking University Shenzhen Hospital, Reproductive Medicine, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhua","family":"Huang","sequence":"additional","affiliation":[{"name":"Hainan Medical College, Reproductive Medicine, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Lu","sequence":"additional","affiliation":[{"name":"Hainan Medical College, Reproductive Medicine, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingpu","family":"Sun","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhengzhou University, Reproductive Medicine, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.fertnstert.2009.09.009","article-title":"International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009.","volume":"9","author":"Vanderpoel","year":"2009","journal-title":"Fertil Steril"},{"key":"2","doi-asserted-by":"publisher","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","article-title":"National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys.","volume":"9","author":"Stevens","year":"2012","journal-title":"PLoS Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0140-6736(78)92957-4","article-title":"Birth after the reimplantation of a human embryo.","volume":"2","author":"Edwards","year":"1978","journal-title":"Lancet"},{"key":"4","first-page":"3","article-title":"Rassegna di clinica, Terapia e scienze affini.","volume":"4","author":"Montezemolo","year":"1949","journal-title":"A Publ Biol Lab Inst Serono"},{"key":"5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/138920112799362007","article-title":"Ovarian stimulation: today and tomorrow.","volume":"1","author":"Devroey","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.fertnstert.2012.02.030","article-title":"History and challenges surrounding ovarian stimulation in the treatment of infertility.","volume":"9","author":"DeCherney","year":"2012","journal-title":"Fertil Steril"},{"key":"7","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.fertnstert.2008.08.031","article-title":"Gonadotropin preparations: past, present, and future perspectives.","volume":"9","author":"Practice Committee of American Society for Reproductive Medicine, Birmingham, Alabama","year":"2008","journal-title":"Fertil Steril"},{"key":"8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1477-7827-3-62","article-title":"Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization.","volume":"3","author":"Scobey","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/humupd\/2.2.172","article-title":"Genetic engineering of human FSH (Gonal-F).","volume":"2","author":"Howles","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/molehr\/2.5.371","article-title":"Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon).","volume":"2","author":"van Wezenbeek","year":"1996","journal-title":"Mol Hum Reprod"},{"key":"11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0140-6736(84)92840-X","article-title":"Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.","volume":"2","author":"Jacobs","year":"1984","journal-title":"Lancet"},{"key":"12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials.","volume":"5","author":"Collins","year":"1992","journal-title":"Fertil Steril"},{"key":"13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/humrep\/3.suppl_2.35","article-title":"Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT","volume":"3","author":"Van Steirteghem","year":"1988","journal-title":"Hum Reprod"},{"key":"14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.fertnstert.2005.02.053","article-title":"Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr.","volume":"8","author":"Oehninger","year":"2005","journal-title":"Fertil Steril"},{"key":"15","unstructured":"IVF Worldwide. Results : The use of GnRH agonist in IVF protocols. The survey includes reports from 273 centres worldwide performing 151,000 IVF cycles annually. https:\/\/www.ivf-worldwide.com\/survey.html."},{"key":"16","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria.","volume":"2","author":"Gianaroli","year":"2011","journal-title":"Hum Reprod"},{"key":"17","volume-title":"Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human follicle stimulating hormone (r-hFSH)","author":"European Medicines Agency, EMA","year":"2013"},{"key":"18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/humrep\/15.8.1691","article-title":"Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group","volume":"1","author":"Donnez","year":"2000","journal-title":"Hum Reprod"},{"key":"19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/humrep\/15.3.520","article-title":"A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists","volume":"1","author":"Truong","year":"2000","journal-title":"Hum Reprod"},{"key":"20","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/humrep\/12.10.2133","article-title":"Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.","volume":"1","author":"Wikland","year":"1997","journal-title":"Hum Reprod"},{"key":"21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.rbmo.2015.01.005","article-title":"A multi-centre phase 3 study comparing efficacy and safety of Bemfola(\u00ae) versus Gonal-f(\u00ae) in women undergoing ovarian stimulation for IVF.","volume":"3","author":"Strowitzki","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0015-0282(99)00450-1","article-title":"A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer.","volume":"7","author":"Loumaye","year":"2000","journal-title":"Fertil Steril"},{"key":"23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-015-0135-8","article-title":"Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap\u00ae (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).","volume":"1","author":"Bias","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.18969","article-title":"How should we report outcomes in reproductive medicine?","volume":"5","author":"Mol","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/humrep\/deh206","article-title":"What is the most relevant standard of success in assisted reproduction? The importance of informed choice.","volume":"1","author":"Tan","year":"2004","journal-title":"Hum Reprod"},{"key":"26","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/humrep\/deh392","article-title":"What is the most relevant standard of success in assisted reproduction? Singleton live births should also include preterm births.","volume":"1","author":"Bergh","year":"2004","journal-title":"Hum Reprod"},{"key":"27","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.fertnstert.2009.11.018","article-title":"Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates?","volume":"9","author":"Herbison","year":"2010","journal-title":"Fertil Steril"},{"key":"28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/humrep\/deh181","article-title":"What is the most relevant standard of success in assisted reproduction?: no single outcome measure is satisfactory when evaluating success in assisted reproduction; both twin births and singleton births should be counted as successes.","volume":"1","author":"Pyrzak","year":"2004","journal-title":"Hum Reprod"},{"key":"29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.fertnstert.2014.03.026","article-title":"Live birth is the correct outcome for clinical trials evaluating therapy for the infertile couple.","volume":"10","author":"Barnhart","year":"2014","journal-title":"Fertil Steril"},{"key":"30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.fertnstert.2014.03.047","article-title":"Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper.","volume":"10","author":"Mol","year":"2014","journal-title":"Fertil Steril"},{"key":"31","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.","volume":"2","author":"Coomarasamy","year":"2011","journal-title":"Hum Reprod"},{"key":"32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.","volume":"10","author":"Muasher","year":"2014","journal-title":"Fertil Steril"},{"key":"33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humrep\/dev316","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"3","author":"Polyzos","year":"2016","journal-title":"Hum Reprod"},{"key":"34","unstructured":"Centers for Disease Control and Prevention. Annual ART success rates reports. Available from: https:\/\/www.cdc.gov\/art\/artdata\/index.html"},{"key":"35","unstructured":"Society for Assisted Reproductive Technology (SART). National Summary Report. https:\/\/www.sartcorsonline.com\/rptCSR_PublicMultYear.aspx?reportingYear=2015."},{"key":"36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0015-0282(02)04583-1","article-title":"A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment.","volume":"7","author":"Thong","year":"2003","journal-title":"Fertil Steril"},{"key":"37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1447-0756.2007.00529.x","article-title":"Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.","volume":"3","author":"Kim","year":"2007","journal-title":"J Obstet Gynaecol Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3109\/09513590.2011.650742","article-title":"Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.","volume":"2","author":"Luo","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"39","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S0015-0282(03)02187-3","article-title":"Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.","volume":"8","author":"van der Veen","year":"2003","journal-title":"Fertil Steril"},{"key":"40","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.05.039","article-title":"Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients","volume":"8","author":"Schats","year":"2008","journal-title":"Fertil Steril"},{"key":"41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.","volume":"9","author":"Broekmans","year":"2009","journal-title":"Fertil Steril"},{"key":"42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.","volume":"2","author":"Sunkara","year":"2014","journal-title":"Hum Reprod Update"},{"key":"43","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.","volume":"10","author":"Havelock","year":"2017","journal-title":"Fertil Steril"},{"key":"44","unstructured":"Veeck. Atlas of the human oocyte and early conceptus. Williams & Wilkins; 1991."}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:08:33Z","timestamp":1599077313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3,31]]}},"alternative-id":["102919","32209728"],"URL":"https:\/\/doi.org\/10.18632\/aging.102919","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]}}}